Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Allan

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|October 1, 1986
Synthesis and biochemical properties of 8-amino-6-fluoro-9-beta-D-ribofuranosyl-9H-purineJ A Secrist, L L Bennett, P W Allan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compoundsL L Bennett, P W Allan, P E Noker, et al.
Biochemical Pharmacology|June 20, 1998
Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cellsW B Parker, P W Allan, S C Shaddix, et al.
Molecular Pharmacology|June 1, 1985
Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferaseL L Bennett, R W Brockman, L M Rose, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Synthesis and biological activity of 2-fluoro adenine and 6-methyl purine nucleoside analogs as prodrugs for suicide gene therapy of cancerA V Silamkoti, P W Allan, A E A Hassan, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidaseL L Bennett, P W Allan, G Arnett, et al.
Toxicology and Applied Pharmacology|November 14, 1997
Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2'-deoxycoformycin in beagle dogsL E Rodman, D R Farnell, J M Coyne, et al.
Molecular Pharmacology|February 11, 1992
Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virusW B Parker, S C Shaddix, P W Allan, et al.
Molecular Pharmacology|December 1, 1993
Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinaseL L Bennett, W B Parker, P W Allan, et al.
Human Gene Therapy|October 10, 1997
In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylaseW B Parker, S A King, P W Allan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|October 1, 1986
Synthesis and biochemical properties of 8-amino-6-fluoro-9-beta-D-ribofuranosyl-9H-purineJ A Secrist, L L Bennett, P W Allan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compoundsL L Bennett, P W Allan, P E Noker, et al.
Biochemical Pharmacology|June 20, 1998
Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cellsW B Parker, P W Allan, S C Shaddix, et al.
Molecular Pharmacology|June 1, 1985
Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferaseL L Bennett, R W Brockman, L M Rose, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Synthesis and biological activity of 2-fluoro adenine and 6-methyl purine nucleoside analogs as prodrugs for suicide gene therapy of cancerA V Silamkoti, P W Allan, A E A Hassan, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidaseL L Bennett, P W Allan, G Arnett, et al.
Toxicology and Applied Pharmacology|November 14, 1997
Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2'-deoxycoformycin in beagle dogsL E Rodman, D R Farnell, J M Coyne, et al.
Molecular Pharmacology|February 11, 1992
Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virusW B Parker, S C Shaddix, P W Allan, et al.
Molecular Pharmacology|December 1, 1993
Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinaseL L Bennett, W B Parker, P W Allan, et al.
Human Gene Therapy|October 10, 1997
In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylaseW B Parker, S A King, P W Allan, et al.
Pageof 3